Boothbay Fund Management’s Chemomab Therapeutics CMMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,547
Closed -$30.4K 1897
2025
Q2
$30.4K Hold
6,547
﹤0.01% 1378
2025
Q1
$28.5K Hold
6,547
﹤0.01% 1315
2024
Q4
$47.4K Sell
6,547
-85
-1% -$537 ﹤0.01% 1361
2024
Q3
$41.7K Hold
6,632
﹤0.01% 1519
2024
Q2
$24.2K Hold
6,632
﹤0.01% 1448
2024
Q1
$20.7K Hold
6,632
﹤0.01% 1505
2023
Q4
$13.5K Hold
6,632
﹤0.01% 1596
2023
Q3
$23.7K Hold
6,632
﹤0.01% 1658
2023
Q2
$34.9K Hold
6,632
﹤0.01% 1693
2023
Q1
$42.2K Sell
6,632
-6,270
-49% -$49.2K ﹤0.01% 2031
2022
Q4
$165K Buy
12,902
+3,559
+38% +$30.7K ﹤0.01% 1664
2022
Q3
$93K Sell
9,343
-982
-10% -$12.7K ﹤0.01% 2057
2022
Q2
$153K Hold
10,325
﹤0.01% 1862
2022
Q1
$198K Buy
10,325
+3,162
+44% +$62.3K ﹤0.01% 1887
2021
Q4
$198K Sell
7,163
-3,702
-34% -$131K ﹤0.01% 1496
2021
Q3
$482K Sell
10,865
-2,817
-21% -$171K 0.01% 1107
2021
Q2
$1.04M Sell
13,682
-1,758
-11% -$172K 0.03% 664
2021
Q1
$1.77M Buy
+15,440
New +$3.07M 0.07% 363

Other funds holding CMMB